Pot Stock Aphria Posts Record Sales as CEO Eyes Deals: Chart

(Bloomberg) -- Medical-marijuana company Aphria Inc. posted a 39 percent jump in second-quarter revenue to C$8.5 million ($6.8 million), exceeding the most recently reported figures of larger peer Aurora Cannabis Inc. and giving it the second-highest quarterly revenue of pot-specialty companies globally. Aphria remains upbeat, even as the increased legalization of marijuana is called into question after a move by U.S. Attorney General Jeff Sessions to revoke policies that allowed its spread and warnings of a possible de-listing. At a conference in Toronto on Wednesday, Chief Executive Officer Vic Neufeld stated plans for several acquisitions that will target expansion in four more states.

--With assistance from David Russell

To contact the reporter on this story: Morwenna Coniam in New York at mconiam@bloomberg.net.

To contact the editors responsible for this story: Arie Shapira at ashapira3@bloomberg.net, Nancy Moran, Morwenna Coniam

©2018 Bloomberg L.P.